Calidi Biotherapeutics, Inc.

0.22 USD
-0.00 (-1.78%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Calidi Biotherapeutics, Inc. stock is down -3.91% since 30 days ago. The next earnings date is Aug 18, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 June’s closed higher than May. 100% of analysts rate it a buy.

About Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. The company was founded in 2014 and is based in San Diego, California.